Vegfr2 / ang2 compounds

MA40013AUndetermined Publication Date: 2015-11-26ELI LILLY & CO

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA40013
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-05-19
Filing Date: 2015-05-12
Publication Date: 2015-11-26

Application Information

Patent Timeline

19 May 2014

Priority

12 May 2015

Application

MA40013

26 Nov 2015

Publication

MA40013A

IPC: A61K39/395; A61P35/00; C07K16/22; C07K16/28; C07K16/46

CPC: A61K2039/505; C07K2317/31; C07K2317/33; C07K2317/622; C07K2317/64; C07K2317/76; C07K2317/92; C07K2317/94

Inventors: LEUNG Donmienne Doen Mun; LIU Ling

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to compounds that bind to human vascular endothelial growth factor receptor-2 (vegfr2) and human angiopoietin-2 (ang2), and may be useful for treating cancer, especially solid tumors driven by vegfr2 and ang2, including gastric, hepatocellular carcinoma, ovarian, colorectal, non-small cell lung, biliary tract, and breast cancers.

Need to check novelty before this filing date? Find Prior Art